Hologic had three patents in big data during Q1 2024. Hologic Inc filed a patent for a system that allows for long-term, real-time monitoring of a wireless implant, such as a biosensor implanted in a breast biopsy cavity. The biosensor detects biochemical parameter data and transmits it wirelessly to a surveillance system for evaluation. This system can help detect trends in a tumor’s microenvironment, monitor treatment progress, and personalize treatment plans. GlobalData’s report on Hologic gives a 360-degree view of the company including its patenting strategy. Buy the report here.

Smarter leaders trust GlobalData

Report-cover

Premium Insights Hologic Inc - Company Profile

Buy the Report

Premium Insights

The gold standard of business intelligence.

Find out more

Hologic grant share with big data as a theme is 66% in Q1 2024. Grant share is based on the ratio of number of grants to total number of patents.

Recent Patents

Application: Wireless active monitoring implant system (Patent ID: US20240065614A1)

The patent filed by Hologic Inc. describes systems and methods for the real-time monitoring of a wireless biosensor implanted in a breast biopsy cavity. The biosensor detects biochemical parameter data and transmits it wirelessly to a surveillance system for evaluation. The evaluation can involve detecting trends in a tumor's microenvironment, monitoring treatment progress, and adjusting treatment for personalized care. The method involves adjusting the set of biochemical parameters to be monitored based on feedback received from an external monitoring device and anatomical measurements related to the breast, enhancing the efficacy of cancer treatment through a closed feedback loop.

Furthermore, the method includes receiving real-time data from the biosensor, transmitting it to an external monitoring device, and evaluating anatomical measurements against changes in biochemical parameters to implement actions that enhance treatment efficacy. The system can apply statistical processing models to compare data to baseline measurements, identify trends in the human body, and determine the effectiveness of treatment. Additionally, the method involves applying trend data to an assessment component to decide on treatments, modify ongoing treatment, provide notifications or warnings, and generate reports related to treatment. The biosensor can be externally powered and activated by a signal from the monitoring device, with the ability to monitor a set of biochemical parameters specified by the device.

To know more about GlobalData’s detailed insights on Hologic, buy the report here.

Premium Insights

From

The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.

GlobalData

GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData Patent Analytics tracks bibliographic data, legal events data, point in time patent ownerships, and backward and forward citations from global patenting offices. Textual analysis and official patent classifications are used to group patents into key thematic areas and link them to specific companies across the world’s largest industries.